These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
640 related articles for article (PubMed ID: 18930767)
1. In vivo expansion of CD4+Foxp3+ regulatory T cells mediated by GITR molecules. Nishioka T; Nishida E; Iida R; Morita A; Shimizu J Immunol Lett; 2008 Dec; 121(2):97-104. PubMed ID: 18930767 [TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human. Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651 [TBL] [Abstract][Full Text] [Related]
3. Resistance of regulatory T cells to glucocorticoid-induced [corrected] TNFR family-related protein (GITR) during Plasmodium yoelii infection. Hisaeda H; Hamano S; Mitoma-Obata C; Tetsutani K; Imai T; Waldmann H; Himeno K; Yasutomo K Eur J Immunol; 2005 Dec; 35(12):3516-24. PubMed ID: 16304635 [TBL] [Abstract][Full Text] [Related]
4. Two distinct mechanisms of augmented antitumor activity by modulation of immunostimulatory/inhibitory signals. Mitsui J; Nishikawa H; Muraoka D; Wang L; Noguchi T; Sato E; Kondo S; Allison JP; Sakaguchi S; Old LJ; Kato T; Shiku H Clin Cancer Res; 2010 May; 16(10):2781-91. PubMed ID: 20460483 [TBL] [Abstract][Full Text] [Related]
5. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice. Qu Y; Zhang B; Zhao L; Liu G; Ma H; Rao E; Zeng C; Zhao Y Transpl Immunol; 2007 Apr; 17(3):153-61. PubMed ID: 17331841 [TBL] [Abstract][Full Text] [Related]
6. "Default" generation of neonatal regulatory T cells. Wang G; Miyahara Y; Guo Z; Khattar M; Stepkowski SM; Chen W J Immunol; 2010 Jul; 185(1):71-8. PubMed ID: 20498359 [TBL] [Abstract][Full Text] [Related]
7. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells. Aarts-Riemens T; Emmelot ME; Verdonck LF; Mutis T Eur J Immunol; 2008 May; 38(5):1381-90. PubMed ID: 18412171 [TBL] [Abstract][Full Text] [Related]
8. Identification of regulatory T cells in systemic lupus erythematosus. Gerli R; Nocentini G; Alunno A; Bocci EB; Bianchini R; Bistoni O; Riccardi C Autoimmun Rev; 2009 Mar; 8(5):426-30. PubMed ID: 19185065 [TBL] [Abstract][Full Text] [Related]
9. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection. He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771 [TBL] [Abstract][Full Text] [Related]
10. Distinct responses of two hepatocellular carcinoma cell lines of a similar origin to immunotherapies targeting regulatory or effector T cells. Nagayama Y; Hase W; Motoyoshi Y; Saitoh O; Sogawa R; Nakao K Oncol Rep; 2007 May; 17(5):1269-73. PubMed ID: 17390075 [TBL] [Abstract][Full Text] [Related]
11. Tumor-specific crosslinking of GITR as costimulation for immunotherapy. Burckhart T; Thiel M; Nishikawa H; Wüest T; Müller D; Zippelius A; Ritter G; Old L; Shiku H; Renner C J Immunother; 2010; 33(9):925-34. PubMed ID: 20948444 [TBL] [Abstract][Full Text] [Related]